TOLINASE Drug Patent Profile
✉ Email this page to a colleague
When do Tolinase patents expire, and what generic alternatives are available?
Tolinase is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in TOLINASE is tolazamide. There are six drug master file entries for this compound. Additional details are available on the tolazamide profile page.
Summary for TOLINASE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Clinical Trials: | 1 |
Patent Applications: | 4,671 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TOLINASE at DailyMed |
Recent Clinical Trials for TOLINASE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Novartis | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for TOLINASE
US Patents and Regulatory Information for TOLINASE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | TOLINASE | tolazamide | TABLET;ORAL | 015500-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | TOLINASE | tolazamide | TABLET;ORAL | 015500-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | TOLINASE | tolazamide | TABLET;ORAL | 015500-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |